Stay updated on Trastuzumab Emtansine in HER2+ Tumors Clinical Trial

Sign up to get notified when there's something new on the Trastuzumab Emtansine in HER2+ Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trastuzumab Emtansine in HER2+ Tumors Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Footer revision updated from v3.2.0 to v3.3.2; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T21:21:21.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The funding-related notice at the bottom of the page has been removed. It previously warned that information might not be up to date due to a lapse in government funding and that NIH operations could be affected.
    Difference
    0.3%
    Check dated 2025-11-17T18:38:35.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page content shows no significant changes to core study information (e.g., study title, conditions, locations, eligibility, primary outcomes); only minor UI and formatting updates are present. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:17:20.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Introducing version v3.2.0 and a government-operating-status notice; removing the older v3.1.0 reference.
    Difference
    3%
    Check dated 2025-10-06T01:59:14.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T23:30:29.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Updated to v3.0.2; removed the Back to Top element; overall content remains largely unchanged.
    Difference
    0.2%
    Check dated 2025-09-14T09:41:19.000Z thumbnail image

Stay in the know with updates to Trastuzumab Emtansine in HER2+ Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trastuzumab Emtansine in HER2+ Tumors Clinical Trial page.